reglab/housing_qa huggingface dataset:
TX Health & Safety Code § 1003.001 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter A. General Provisions|Section 1003.001. Establishment of Adult Stem Cell Bank

Sec. 1003.001.  ESTABLISHMENT OF ADULT STEM CELL BANK.  (a)  If the executive commissioner of the Health and Human Services Commission determines that it will be cost-effective and increase the efficiency or quality of health care, health and human services, and health benefits programs in this state, the executive commissioner by rule shall establish eligibility criteria for the creation and operation of an autologous adult stem cell bank.(b)  In adopting the rules under Subsection (a), the executive commissioner shall consider:(1)  the ability of the applicant to establish, operate, and maintain an autologous adult stem cell bank and to provide related services; and(2)  the demonstrated experience of the applicant in operating similar facilities in this state.(c)  This section does not affect the application of or apply to Chapter 162.|Added by Acts 2011, 82nd Leg., 1st C.S., Ch. 7 (S.B. 7), Sec. 14.01, eff. September 28, 2011.|
TX Health & Safety Code § 1003.002 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter A. General Provisions|Section 1003.002. General Requirements for Adult Stem Cell Use in Health Care

Sec. 1003.002.  GENERAL REQUIREMENTS FOR ADULT STEM CELL USE IN HEALTH CARE.  A person using adult stem cells in the provision of health care:(1)  must use adult stem cells that are properly manufactured and stored; and(2)  may only use adult stem cells in a clinical trial approved by the United States Food and Drug Administration.|Added by Acts 2015, 84th Leg., R.S., Ch. 992 (H.B. 177), Sec. 5, eff. September 1, 2015.|
TX Health & Safety Code § 1003.003 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter A. General Provisions|Section 1003.003. Additional Requirements for Adult Stem Cell Use in Hospitals

Sec. 1003.003.  ADDITIONAL REQUIREMENTS FOR ADULT STEM CELL USE IN HOSPITALS.  A hospital may use adult stem cells in a procedure if:(1)  a physician providing services at the hospital determines that the use of adult stem cells in the procedure is appropriate;(2)  the patient consents in writing to the use;(3)  the requirements for stem cell use under Section 1003.002 are met;(4)  the manufacturing processes for the adult stem cells satisfy current good manufacturing practices adopted by the United States Food and Drug Administration; and(5)  appropriate state and federal guidelines on the use of adult stem cells are followed.|Added by Acts 2015, 84th Leg., R.S., Ch. 992 (H.B. 177), Sec. 5, eff. September 1, 2015.|
TX Health & Safety Code § 1003.051 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.051. Definitions

Sec. 1003.051.  DEFINITIONS.  In this subchapter:(1)  "Investigational stem cell treatment" means an adult stem cell treatment that:(A)  is under investigation in a clinical trial and being administered to human participants in that trial; and(B)  has not yet been approved for general use by the United States Food and Drug Administration.(2)  "Severe chronic disease" means a condition, injury, or illness that:(A)  may be treated;(B)  is never cured or eliminated; and(C)  entails significant functional impairment or severe pain.(3)  "Terminal illness" means an advanced stage of a disease with an unfavorable prognosis that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.|
TX Health & Safety Code § 1003.052 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.052. Rules

Sec. 1003.052.  RULES.  The executive commissioner shall adopt rules designating the medical conditions that constitute a severe chronic disease or terminal illness for purposes of this subchapter.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.|
TX Health & Safety Code § 1003.0525 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.0525. Administration of Subchapter

Sec. 1003.0525.  ADMINISTRATION OF SUBCHAPTER.  The department shall administer this subchapter.|Added by Acts 2019, 86th Leg., R.S., Ch. 1158 (H.B. 3148), Sec. 1, eff. September 1, 2019.|
TX Health & Safety Code § 1003.0526 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.0526. Investigational Stem Cell Registry

Sec. 1003.0526.  INVESTIGATIONAL STEM CELL REGISTRY.  The department shall establish and maintain an investigational stem cell registry that lists each physician who administers an investigational stem cell treatment under this subchapter.|Added by Acts 2019, 86th Leg., R.S., Ch. 1158 (H.B. 3148), Sec. 1, eff. September 1, 2019.|
TX Health & Safety Code § 1003.053 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.053. Patient Eligibility

Sec. 1003.053.  PATIENT ELIGIBILITY.  A patient is eligible to access and use an investigational stem cell treatment under this subchapter if:(1)  the patient has a severe chronic disease or terminal illness listed in the rules adopted under Section 1003.052 and attested to by the patient's treating physician; and(2)  the patient's physician:(A)  in consultation with the patient, has considered all other treatment options currently approved by the United States Food and Drug Administration and determined that those treatment options are unavailable or unlikely to alleviate the significant impairment or severe pain associated with the severe chronic disease or terminal illness; and(B)  has recommended or prescribed in writing that the patient use a specific class of investigational stem cell treatment.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.|
TX Health & Safety Code § 1003.054 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.054. Informed Consent

Sec. 1003.054.  INFORMED CONSENT.  (a)  Before receiving an investigational stem cell treatment, an eligible patient must sign a written informed consent.(b)  If the patient is a minor or lacks the mental capacity to provide informed consent, a parent, guardian, or conservator may provide informed consent on the patient's behalf.(c)  The executive commissioner by rule shall adopt a form for the informed consent under this section. The form must provide notice that the department administers this subchapter.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.Amended by: Acts 2019, 86th Leg., R.S., Ch. 1158 (H.B. 3148), Sec. 2, eff. September 1, 2019.|
TX Health & Safety Code § 1003.055 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.055. Treatment Requirements; Texas Medical Board Rules

Sec. 1003.055.  TREATMENT REQUIREMENTS; TEXAS MEDICAL BOARD RULES.  (a)  Treatment provided under this subchapter must be:(1)  administered directly by a physician certified under Subsection (c);(2)  overseen by an institutional review board described by Subsection (d); and(3)  provided at:(A)  a hospital licensed under Chapter 241;(B)  an ambulatory surgical center licensed under Chapter 243; or(C)  a medical school, as defined by Section 61.501, Education Code.(b)  A physician administering an investigational stem cell treatment under this subchapter shall comply with all applicable Texas Medical Board rules.(c)  An institutional review board described by Subsection (d) may certify a physician to provide an investigational stem cell treatment under this subchapter.(d)  An institutional review board that oversees investigational stem cell treatments administered under this subchapter must meet one of the following conditions:(1)  be affiliated with a medical school, as defined by Section 61.501, Education Code;(2)  be affiliated with a hospital licensed under Chapter 241 that has at least 150 beds;(3)  be accredited by the Association for the Accreditation of Human Research Protection Programs;(4)  be registered by the United States Department of Health and Human Services, Office for Human Research Protections, in accordance with 21 C.F.R. Part 56; or(5)  be accredited by a national accreditation organization acceptable to the Texas Medical Board.(e)  The Texas Medical Board may adopt rules regarding institutional review boards as necessary to implement this section.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.Amended by: Acts 2019, 86th Leg., R.S., Ch. 1158 (H.B. 3148), Sec. 3, eff. September 1, 2019.|
TX Health & Safety Code § 1003.056 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.056. Effect on Other Law

Sec. 1003.056.  EFFECT ON OTHER LAW.  (a)  This subchapter does not affect the coverage of enrollees in clinical trials under Chapter 1379, Insurance Code.(b)  This subchapter does not affect or authorize a person to violate any law regulating the possession, use, or transfer of fetal tissue, fetal stem cells, adult stem cells, or human organs, including Sections 48.02 and 48.04, Penal Code.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.Amended by: Acts 2019, 86th Leg., R.S., Ch. 467 (H.B. 4170), Sec. 21.002(13), eff. September 1, 2019.|
TX Health & Safety Code § 1003.057 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.057. Action Against Physician's License Prohibited

Sec. 1003.057.  ACTION AGAINST PHYSICIAN'S LICENSE PROHIBITED.  Notwithstanding any other law, the Texas Medical Board may not revoke, fail  to renew, suspend, or take any action against a physician's license under Subchapter B, Chapter 164, Occupations Code, based solely on the physician's recommendations to an eligible patient regarding access to or use of an investigational stem cell treatment, provided that the care provided or recommendations made to the patient meet the standard of care and the requirements of this subchapter.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.|
TX Health & Safety Code § 1003.058 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.058. Governmental Interference Prohibited

Sec. 1003.058.  GOVERNMENTAL INTERFERENCE PROHIBITED.  (a)  In this section, "governmental entity" means this state or an agency or political subdivision of this state.(b)  A governmental entity or an officer, employee, or agent of a governmental entity may not interfere with an eligible patient's access to or use of an investigational stem cell treatment authorized under this subchapter unless the treatment uses an adult stem cell product that is considered an adulterated or misbranded drug under Chapter 431. For purposes of this subsection, a governmental entity may not consider the adult stem cell product to be an adulterated or misbranded drug solely on the basis that the United States Food and Drug Administration has not approved the adult stem cell product.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.Amended by: Acts 2019, 86th Leg., R.S., Ch. 1158 (H.B. 3148), Sec. 4, eff. September 1, 2019.|
TX Health & Safety Code § 1003.059 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.059. Institutional Review Board Documentation; Report

Sec. 1003.059.  INSTITUTIONAL REVIEW BOARD DOCUMENTATION; REPORT.  (a)  An institutional review board overseeing an investigational stem cell treatment under this subchapter shall keep a record on each person to whom a physician administers the treatment and document in the record the provision of each treatment and the effects of the treatment on the person throughout the period the treatment is administered to the person.(b)  Each institutional review board overseeing an investigational stem cell treatment under this subchapter shall submit an annual report to the Texas Medical Board on the review board's findings based on records kept under Subsection (a).  The report may not include any patient identifying information and must be made available to the public in both written and electronic form.|Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.|
TX Health & Safety Code § 1003.060 (2021)
2021 Texas Statutes|Health and Safety Code|Title 12 - Health and Mental Health|Chapter 1003 - Adult Stem Cells|Subchapter B. Provision of Investigational Stem Cell Treatments to Patients With Certain Severe Chronic Diseases or Terminal Illnesses|Section 1003.060. Construction of Subchapter

Sec. 1003.060.  CONSTRUCTION OF SUBCHAPTER.  This subchapter may not be construed to:(1)  prohibit a physician from using adult stem cells for their intended homologous use if the stem cells are:(A)  produced by a manufacturer registered by the United States Food and Drug Administration; and(B)  commercially available; or(2)  require an institutional review board to oversee treatment using adult stem cells registered by the United States Food and Drug Administration for their intended homologous use.|Added by Acts 2019, 86th Leg., R.S., Ch. 1158 (H.B. 3148), Sec. 5, eff. September 1, 2019.|
TX Health & Safety Code § 1101.001 (2021)
2021 Texas Statutes|Health and Safety Code|Title 13 - Environmental, Health, and Safety Audit Privilege Act|Chapter 1101 - Environmental, Health, and Safety Audit Privilege Act|Subchapter A. General Provisions|Section 1101.001. Short Title

Sec. 1101.001.  SHORT TITLE.  This chapter may be cited as the Texas Environmental, Health, and Safety Audit Privilege Act.  |Added by Acts 2017, 85th Leg., R.S., Ch. 324 (S.B. 1488), Sec. 20.002(a), eff. September 1, 2017.|
TX Health & Safety Code § 1101.002 (2021)
2021 Texas Statutes|Health and Safety Code|Title 13 - Environmental, Health, and Safety Audit Privilege Act|Chapter 1101 - Environmental, Health, and Safety Audit Privilege Act|Subchapter A. General Provisions|Section 1101.002. Purpose; Circumvention by Rule Prohibited

Sec. 1101.002.  PURPOSE; CIRCUMVENTION BY RULE PROHIBITED.  (a)  The purpose of this chapter is to encourage voluntary compliance with environmental and occupational health and safety laws.(b)  A regulatory agency may not adopt a rule or impose a condition that circumvents the purpose of this chapter.|Added by Acts 2017, 85th Leg., R.S., Ch. 324 (S.B. 1488), Sec. 20.002(a), eff. September 1, 2017.|
TX Health & Safety Code § 1101.003 (2021)
2021 Texas Statutes|Health and Safety Code|Title 13 - Environmental, Health, and Safety Audit Privilege Act|Chapter 1101 - Environmental, Health, and Safety Audit Privilege Act|Subchapter A. General Provisions|Section 1101.003. Definitions

Sec. 1101.003.  DEFINITIONS.  (a)  In this chapter:(1)  "Acquisition closing date" means the date on which ownership of, or a direct or indirect majority interest in the ownership of, a regulated facility or operation is acquired in an asset purchase, equity purchase, merger, or similar transaction.(2)  "Audit report" means an audit report described by Section 1101.051.(3)  "Environmental or health and safety audit" or "audit" means a systematic voluntary evaluation, review, or assessment of compliance with environmental or health and safety laws or with any permit issued under an environmental or health and safety law conducted by an owner or operator, an employee of an owner or operator, a person, including an employee or independent contractor of the person, that is considering the acquisition of a regulated facility or operation, or an independent contractor of:(A)  a regulated facility or operation; or(B)  an activity at a regulated facility or operation.(4)  "Environmental or health and safety law" means:(A)  a federal or state environmental or occupational health and safety law; or(B)  a rule, regulation, or regional or local law adopted in conjunction with a law described by Paragraph (A).(5)  "Owner or operator" means a person who owns or operates a regulated facility or operation.(6)  "Penalty" means an administrative, civil, or criminal sanction imposed by the state to punish a person for a violation of a statute or rule.  The term does not include a technical or remedial provision ordered by a regulatory authority.(7)  "Regulated facility or operation" means a facility or operation that is regulated under an environmental or health and safety law.(b)  A person acts intentionally for purposes of this chapter if the person acts intentionally within the meaning of Section 6.03, Penal Code.(c)  For purposes of this chapter, a person acts knowingly, or with knowledge, with respect to the nature of the person's conduct when the person is aware of the person's physical acts.  A person acts knowingly, or with knowledge, with respect to the result of the person's conduct when the person is aware that the conduct will cause the result.(d)  A person acts recklessly or is reckless for purposes of this chapter if the person acts recklessly or is reckless within the meaning of Section 6.03, Penal Code.(e)  To fully implement the privilege established by this chapter, the term "environmental or health and safety law" shall be construed broadly.  |Added by Acts 2017, 85th Leg., R.S., Ch. 324 (S.B. 1488), Sec. 20.002(a), eff. September 1, 2017.|
TX Health & Safety Code § 1101.004 (2021)
2021 Texas Statutes|Health and Safety Code|Title 13 - Environmental, Health, and Safety Audit Privilege Act|Chapter 1101 - Environmental, Health, and Safety Audit Privilege Act|Subchapter A. General Provisions|Section 1101.004. Applicability

Sec. 1101.004.  APPLICABILITY.  The privilege established by this chapter applies to environmental or health and safety audits that are conducted on or after May 23, 1995.  |Added by Acts 2017, 85th Leg., R.S., Ch. 324 (S.B. 1488), Sec. 20.002(a), eff. September 1, 2017.|
TX Health & Safety Code § 1101.005 (2021)
2021 Texas Statutes|Health and Safety Code|Title 13 - Environmental, Health, and Safety Audit Privilege Act|Chapter 1101 - Environmental, Health, and Safety Audit Privilege Act|Subchapter A. General Provisions|Section 1101.005. Relationship to Other Recognized Privileges

Sec. 1101.005.  RELATIONSHIP TO OTHER RECOGNIZED PRIVILEGES. This chapter does not limit, waive, or abrogate the scope or nature of any statutory or common law privilege, including the work product doctrine and the attorney-client privilege.  |Added by Acts 2017, 85th Leg., R.S., Ch. 324 (S.B. 1488), Sec. 20.002(a), eff. September 1, 2017.|
TX Health & Safety Code § 1101.051 (2021)
2021 Texas Statutes|Health and Safety Code|Title 13 - Environmental, Health, and Safety Audit Privilege Act|Chapter 1101 - Environmental, Health, and Safety Audit Privilege Act|Subchapter B. General Audit Provisions|Section 1101.051. Audit Report

Sec. 1101.051.  AUDIT REPORT.  (a)  An audit report is a report that includes each document and communication, other than those described by Section 1101.102, produced from an environmental or health and safety audit.(b)  General components that may be contained in a completed audit report include:(1)  a report prepared by an auditor, monitor, or similar person, which may include:(A)  a description of the scope of the audit;(B)  the information gained in the audit and findings, conclusions, and recommendations; and(C)  exhibits and appendices;(2)  memoranda and documents analyzing all or a portion of the materials described by Subdivision (1) or discussing implementation issues; and(3)  an implementation plan or tracking system to correct past noncompliance, improve current compliance, or prevent future noncompliance.(c)  The types of exhibits and appendices that may be contained in an audit report include supporting information that is collected or developed for the primary purpose of and in the course of an environmental or health and safety audit, including:(1)  interviews with current or former employees;(2)  field notes and records of observations;(3)  findings, opinions, suggestions, conclusions, guidance, notes, drafts, and memoranda;(4)  legal analyses;(5)  drawings;(6)  photographs;(7)  laboratory analyses and other analytical data;(8)  computer-generated or electronically recorded information;(9)  maps, charts, graphs, and surveys; and(10)  other communications associated with an environmental or health and safety audit.(d)  To facilitate identification, each document in an audit report should be labeled "COMPLIANCE REPORT:  PRIVILEGED DOCUMENT" or labeled with words of similar import.  Failure to label a document under this section does not constitute a waiver of the privilege established by this chapter or create a presumption that the privilege does or does not apply.|Added by Acts 2017, 85th Leg., R.S., Ch. 324 (S.B. 1488), Sec. 20.002(a), eff. September 1, 2017.|
TX Health & Safety Code § 1101.052 (2021)
2021 Texas Statutes|Health and Safety Code|Title 13 - Environmental, Health, and Safety Audit Privilege Act|Chapter 1101 - Environmental, Health, and Safety Audit Privilege Act|Subchapter B. General Audit Provisions|Section 1101.052. Period for Completion of Audit

Sec. 1101.052.  PERIOD FOR COMPLETION OF AUDIT.  (a)  Unless an extension is approved by the governmental entity with regulatory authority over the regulated facility or operation based on reasonable grounds, an environmental or health and safety audit must be completed within a reasonable time not to exceed six months after:(1)  the date the audit is initiated; or(2)  the acquisition closing date, if the person continues the audit under Section 1101.053.(b)  Subsection (a)(1) does not apply to an environmental or health and safety audit conducted before the acquisition closing date by a person that is considering the acquisition of the regulated facility or operation.|Added by Acts 2017, 85th Leg., R.S., Ch. 324 (S.B. 1488), Sec. 20.002(a), eff. September 1, 2017.|